LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,055,000 | +55.0% | 45,192 | +0.7% | 0.59% | +5.7% |
| Q1 2020 | $3,262,000 | -28.1% | 44,859 | +3.2% | 0.56% | -4.0% |
| Q4 2019 | $4,535,000 | -8.1% | 43,483 | -12.3% | 0.58% | -22.3% |
| Q3 2019 | $4,935,000 | -56.2% | 49,578 | -49.7% | 0.75% | -52.3% |
| Q2 2019 | $11,261,000 | -31.9% | 98,649 | -25.0% | 1.56% | -27.2% |
| Q1 2019 | $16,538,000 | +29.1% | 131,559 | +39.4% | 2.15% | +5.2% |
| Q4 2018 | $12,808,000 | -36.1% | 94,382 | +29.3% | 2.04% | -36.9% |
| Q3 2018 | $20,043,000 | -21.0% | 73,020 | -40.4% | 3.23% | -18.1% |
| Q2 2018 | $25,371,000 | +31.5% | 122,463 | +4.8% | 3.95% | -6.8% |
| Q1 2018 | $19,292,000 | +25.8% | 116,808 | +4.3% | 4.24% | +0.8% |
| Q4 2017 | $15,332,000 | +77.8% | 111,971 | +76.8% | 4.20% | +53.9% |
| Q3 2017 | $8,625,000 | +13.5% | 63,346 | +1.2% | 2.73% | +7.1% |
| Q2 2017 | $7,602,000 | +14.7% | 62,623 | -0.0% | 2.55% | +0.8% |
| Q1 2017 | $6,630,000 | +58.4% | 62,640 | +52.1% | 2.53% | +37.6% |
| Q4 2016 | $4,185,000 | -0.4% | 41,190 | +0.0% | 1.84% | +1.6% |
| Q3 2016 | $4,203,000 | -16.3% | 41,177 | -2.2% | 1.81% | -22.3% |
| Q2 2016 | $5,024,000 | -17.3% | 42,120 | -25.7% | 2.33% | -24.0% |
| Q1 2016 | $6,073,000 | -1.4% | 56,711 | -0.2% | 3.06% | +18.8% |
| Q4 2015 | $6,160,000 | +24.9% | 56,818 | -1.3% | 2.58% | +5.9% |
| Q3 2015 | $4,931,000 | -0.5% | 57,571 | +17.2% | 2.44% | +4.5% |
| Q2 2015 | $4,956,000 | -29.7% | 49,115 | -46.3% | 2.33% | -35.2% |
| Q1 2015 | $7,047,000 | +61.6% | 91,384 | +11.5% | 3.60% | +45.6% |
| Q4 2014 | $4,361,000 | +21.5% | 81,952 | +7.3% | 2.47% | +0.7% |
| Q3 2014 | $3,588,000 | -22.5% | 76,366 | +2.7% | 2.45% | -21.4% |
| Q2 2014 | $4,632,000 | -1.9% | 74,363 | +6.0% | 3.12% | -6.7% |
| Q1 2014 | $4,720,000 | +48.9% | 70,162 | +16.5% | 3.34% | +24.5% |
| Q4 2013 | $3,169,000 | – | 60,242 | – | 2.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |